Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FZD7 |
| Upstream (Parents) |
|---|
| (<<) AIFM1 → FZD7 |
| (<<) BDH1 → FZD7 |
| (<<) CASP5 → FZD7 |
| (<<) ELF3 → FZD7 |
| (<<) ENO3 → FZD7 |
| (<<) GOT1 → FZD7 |
| (<<) KLF4 → FZD7 |
| (<<) MAP2K1 → FZD7 |
| (<<) MT1F → FZD7 |
| (<<) PLCG1 → FZD7 |
| (<<) STYK1 → FZD7 |
| Downstream (Children) |
|---|
| FZD7 → APH1B (>>) |
| FZD7 → CORO1A (>>) |
| FZD7 → FOS (>>) |
| FZD7 → FZD2 (>>) |
| FZD7 → IL1F7 (>>) |
| FZD7 → JAK2 (>>) |
| FZD7 → JUND (>>) |
| FZD7 → MAP3K8 (>>) |
| FZD7 → MTAP (>>) |
| FZD7 → NFATC3 (>>) |
| FZD7 → RPS6KA5 (>>) |
| FZD7 → RPS6KB2 (>>) |
| FZD7 → TMEM158 (>>) |
| FZD7 → ZNF205 (>>) |
